MenHibrix

Meningococcal C and Y/?haemophilus influenza type B vaccine is used for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroups C and Y and Haemophilus influenzae type b.

Meningococcal C and Y/?haemophilus influenza type B vaccine are available under the following different brand names: MenHibrix.

Solution for Injection

• Single-dose vial of lyophilized vaccine, 0.5 mL

Dosage Considerations – Should be Given as Follows:

• Four doses (0.5 mL each) by intramuscular injection at 2, 4, 6, and 12 through 15 months of age. The first dose may be given as early as 6 weeks of age. The fourth dose may be given as late as 18 months of age.
• Approved for use in children 6 weeks of age through 18 months of age

Common side effects of meningococcal C and Y/?haemophilus influenza type B vaccine include:

• Injection site reactions (pain, redness, swelling)
• Irritability
• Drowsiness
• Loss of appetite
• Fever

This document does not contain all possible side effects and others may occur. Check with your physician for additional information about side effects.

If your doctor has directed you to use this medication, your doctor or pharmacist may already be aware of any possible drug interactions and may be monitoring you for them. Do not start, stop, or change the dosage of any medicine before checking with your doctor, health care provider or pharmacist first.

Interactions of meningococcal C and Y/?haemophilus influenza type B vaccine include:

• Immunosuppressive therapies, including irradiation, antimetabolites, alkylating agents, 202 cytotoxic drugs, and corticosteroids

This document does not contain all possible interactions. Therefore, before using this product, tell your doctor or pharmacist of all the products you use. Keep a list of all your medications with you, and share the list with your doctor and pharmacist. Check with your physician if you have health questions or concerns.

Warnings
 

This medication contains meningococcal C and Y/?haemophilus influenza type B vaccine. Do not take MenHibrix if you are allergic to meningococcal C and Y/?haemophilus influenza type B vaccine or any ingredients contained in this drug.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center immediately.

Contraindications

• Severe allergic reaction (e.g., anaphylaxis) after a previous dose of any meningococcal-, H. influenzae type b-, or tetanus toxoid-containing vaccine or any component of meningococcal C and Y/?haemophilus influenza type B vaccine.

Effects of Drug Abuse

• No information available

Short-Term Effects

• See "What Are Side Effects Associated with Using Meningococcal C and Y/?Haemophilus Influenza Type B Vaccine?”

Long-Term Effects

• See "What Are Side Effects Associated with Using Meningococcal C and Y/?Haemophilus Influenza Type B Vaccine?”

Cautions

• If Guillain-Barré syndrome has occurred within 6 weeks of receipt of a prior vaccine containing tetanus toxoid, the decision to give any tetanus toxoid-containing vaccine, including meningococcal C and Y/?haemophilus influenza type B vaccine, should be based on consideration of the potential benefits and possible risks.
• Syncope (fainting) can occur in association with the administration of injectable vaccines, including meningococcal C and Y/?haemophilus influenza type B vaccine. Procedures should be in place to avoid falling injury and to restore cerebral perfusion following syncope.
• Apnea following intramuscular vaccination has been observed in some infants born prematurely. Decisions about when to administer an intramuscular vaccine, including meningococcal C and Y/?haemophilus influenza type B vaccine, to infants born prematurely, should be based on consideration of the individual infant’s medical status, and the potential benefits and possible risks of vaccination.

Pregnancy and Lactation

Animal reproduction studies have not been conducted with meningococcal C and Y/?haemophilus influenza type B vaccine. It is also not known whether meningococcal C and Y/?haemophilus influenza type B vaccine can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Consult your doctor.